BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33934828)

  • 1. Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.
    Chappell DL; White MC; Damania B
    Adv Virus Res; 2021; 109():201-254. PubMed ID: 33934828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gammaherpesvirus MicroRNA Targets EWSR1 (Ewing Sarcoma Breakpoint Region 1)
    Wang Y; Feldman ER; Bullard WL; Tibbetts SA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rewiring of the Host Cell Metabolome and Lipidome during Lytic Gammaherpesvirus Infection Is Essential for Infectious-Virus Production.
    Clark SA; Vazquez A; Furiya K; Splattstoesser MK; Bashmail AK; Schwartz H; Russell M; Bhark SJ; Moreno OK; McGovern M; Owsley ER; Nelson TA; Sanchez EL; Delgado T
    J Virol; 2023 Jun; 97(6):e0050623. PubMed ID: 37191529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus Epigenetic Reprogramming and Oncogenesis.
    Pei Y; Wong JH; Robertson ES
    Annu Rev Virol; 2020 Sep; 7(1):309-331. PubMed ID: 32991266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomal Toll-Like Receptors 7 and 9 Cooperate in Detection of Murine Gammaherpesvirus 68 Infection.
    Bussey KA; Murthy S; Reimer E; Chan B; Hatesuer B; Schughart K; Glaunsinger B; Adler H; Brinkmann MM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of murine gammaherpesvirus 68 miRNA-mRNA hybrids reveals miRNA target conservation among gammaherpesviruses including host translation and protein modification machinery.
    Bullard WL; Kara M; Gay LA; Sethuraman S; Wang Y; Nirmalan S; Esemenli A; Feswick A; Hoffman BA; Renne R; Tibbetts SA
    PLoS Pathog; 2019 Aug; 15(8):e1007843. PubMed ID: 31393953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; StĆ¼rzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conquering the Host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68.
    Wang Y; Tibbetts SA; Krug LT
    Annu Rev Virol; 2021 Sep; 8(1):349-371. PubMed ID: 34586873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine Gammaherpesvirus 68: A Small Animal Model for Gammaherpesvirus-Associated Diseases.
    Dong S; Forrest JC; Liang X
    Adv Exp Med Biol; 2017; 1018():225-236. PubMed ID: 29052141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB inhibits gammaherpesvirus lytic replication.
    Brown HJ; Song MJ; Deng H; Wu TT; Cheng G; Sun R
    J Virol; 2003 Aug; 77(15):8532-40. PubMed ID: 12857922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting the message direct manipulation of host mRNA accumulation during gammaherpesvirus lytic infection.
    Clyde K; Glaunsinger BA
    Adv Virus Res; 2010; 78():1-42. PubMed ID: 21040830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms in murine gammaherpesvirus-68 infection.
    Stevenson PG; Efstathiou S
    Viral Immunol; 2005; 18(3):445-56. PubMed ID: 16212523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis.
    Bullard WL; Flemington EK; Renne R; Tibbetts SA
    Trends Cancer; 2018 Nov; 4(11):729-740. PubMed ID: 30352676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo.
    Feldman ER; Kara M; Coleman CB; Grau KR; Oko LM; Krueger BJ; Renne R; van Dyk LF; Tibbetts SA
    mBio; 2014 May; 5(3):e00981-14. PubMed ID: 24865551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of a novel vaccination strategy for human gamma-herpesviruses.
    Wu TT; Blackman MA; Sun R
    Immunol Res; 2010 Dec; 48(1-3):122-46. PubMed ID: 20717741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFITM1 expression is crucial to gammaherpesvirus infection, in vivo.
    Hussein HAM; Briestenska K; Mistrikova J; Akula SM
    Sci Rep; 2018 Sep; 8(1):14105. PubMed ID: 30237526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus (
    Yakushina SA; Kisteneva LB
    Vopr Virusol; 2020 Sep; 65(4):191-202. PubMed ID: 33533222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus EBER1 and murine gammaherpesvirus TMER4 share conserved in vivo function to promote B cell egress and dissemination.
    Hoffman BA; Wang Y; Feldman ER; Tibbetts SA
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25392-25394. PubMed ID: 31796588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host.
    Little RF; Yarchoan R
    Semin Hematol; 2003 Apr; 40(2):163-71. PubMed ID: 12704593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.